Ephrin B1 anticorps (Extracellular Domain)
Aperçu rapide pour Ephrin B1 anticorps (Extracellular Domain) (ABIN7043131)
Antigène
Voir toutes Ephrin B1 (EFNB1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 208-221, Extracellular Domain
-
Fonction
- A Rabbit Polyclonal Antibody to Ephrin-B1
-
Réactivité croisée
- Humain, Souris
-
Homologie
- Mouse - identical, rat - 13,14 amino acid residues identical
-
Attributs du produit
- Anti-Ephrin-B1 (extracellular) Antibody is directed against an epitope of human Ephrin-B1. Anti-Ephrin-B1 (extracellular) Antibody (ABIN7043131, ABIN7044261 and ABIN7044262) can be used in western blot analysis. The antibody recognizes an extracellular epitope and is thus ideal for detecting the ligand in living cells. It has been designed to recognize Ephrin-B1 from human, rat and mouse samples.
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogène
- (C)KHETVNQEEKSGPG, corresponding to amino acid residues 208-221 of human Ephrin-B1
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:200
FC: 2.5 μg per reaction
ICC: The optimal concentration should be determined by the user
IHC: The optimal concentration should be determined by the user
IP: The optimal concentration should be determined by the user
-
Commentaires
-
Negative Control: (ABIN7235313)
Blocking Peptide: (ABIN7235313)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.
-
Concentration
- 0.8 mg/mL
-
Buffer
- PBS pH 7.4, 1 % BSA with 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- Ephrin B1 (EFNB1)
-
Autre désignation
- EFNB1
-
Sujet
-
Synonyms: EPH-related receptor tyrosine kinase ligand 2, LERK2, EFNB1
Description: The erythropoietin-producing hepatocellular (EPH) receptors represent the largest known family of receptor tyrosine kinases and are activated by interactions with cell-surface ligands, termed EFNs. EPH receptors have been classified into two subfamilies, EPHA and EPHB, according to their preference for either glycosylphosphatidylinositol (GPI)-anchored EFN-A ligands or transmembrane EFN-B ligands. Thus far, 14 vertebrate receptors and eight ligands have been identified1. All the ligands share a conserved core sequence of approximately 125 amino acids, including 4 invariant cysteine residues, probably corresponding to a receptor binding domain. This is followed by a membrane anchorage domain, taking the form of a GPI anchor for five of the ligands (ephrin-A1 to -A5) or a transmembrane domain for three of them (ephrin-B1 to -B3) 2.Ephrin-B1 is signals forward or reverse signaling mechanisms. Ephrin-B1 PDZ-dependent reverse signaling controls axon guidance of the corpus callosum, whereas forward signaling is critical for normal craniofacial development2.Eph receptors and ephrins are highly expressed in the brain and in the developing nervous system, where they are involved in fundamental developmental processes of the nervous system, including axon guidance, axonfasciculation, neural crest cell migration, acquisition of brain subregional identity,and neuronal cell survival. Ephrins are dramatically expressed in a wide range of regions of the vertebrate embryo including the ectoderm, mesoderm, and endoderm3.Overexpression of B-type ephrin in cancer cells is reported to correlate with high invasion and high vascularity of tumors and elevated expression of ephrin-B1 is observed in poorly differentiated invasive tumor cells and other tumors with poor clinical prognosis4.
-
ID gène
- 1947
-
NCBI Accession
- NM_004429
-
UniProt
- P98172
-
Pathways
- Signalisation RTK
Antigène
-